Metabolic Weaknesses Exposed in Prostate Cancer That Resists Enzalutamide
Multi-omic profiling of enzalutamide-resistant prostate cancer cells has revealed rewired lipid, glutamine and mitochondrial metabolism that creates druggable vulnerabilities and ...
